Floatz logo

White Blood Cells/Granulocytes

Advanced Cancer

Wuxi People's HospitalCell therapyPhase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
73/ 100

Competitive context

93 Active assets in the Advanced Cancer cohort.

Asset / SponsorPhaseRating
Nabiximols
Jazz Pharmaceuticals
Phase 3BBB
Rivoceranib
Jiangsu HengRui Medicine Co., Ltd.
Phase 4BB
Osimertinib
NING LI
Phase 4BB
Ipilimumab
7 Hills Pharma, LLC
Phase 2BB
Irinotecan
MOMA Therapeutics
Phase 3BB

View all 50 →

Same molecule, other indications

White Blood Cells/Granulocytes is also rated in:

disease related to hematopoietic stem cell transplantDormant
CCC
Indicative ·
48 / 100
View asset →
Cord Blood Stem Cell TransplantationDormant
CCC
Indicative ·
48 / 100
View asset →
neoplasmDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →